DrugPatentWatch Database Preview
Calcium carbonate; famotidine; magnesium hydroxide - Generic Drug Details
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What are the generic sources for calcium carbonate; famotidine; magnesium hydroxide and what is the scope of patent protection?
Calcium carbonate; famotidine; magnesium hydroxide
is the generic ingredient in two branded drugs marketed by Perrigo R And D and J And J Consumer Inc, and is included in three NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.There are two hundred and eighty-two drug master file entries for calcium carbonate; famotidine; magnesium hydroxide. Twenty-five suppliers are listed for this compound.
Summary for calcium carbonate; famotidine; magnesium hydroxide
| US Patents: | 1 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 3 |
| Drug Master File Entries: | 282 |
| Suppliers / Packagers: | 25 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for calcium carbonate; famotidine; magnesium hydroxide |
| DailyMed Link: | calcium carbonate; famotidine; magnesium hydroxide at DailyMed |
Recent Litigation for calcium carbonate; famotidine; magnesium hydroxide
Identify potential future generic entrants
District Court Litigation
| Case Name | Date |
|---|---|
| Brigham and Women's Hospital, Inc. v. Perrigo Company | 2013-07-09 |
| Santarus Inc. v. Par Pharmaceutical Inc. | 2007-09-13 |
| Pfizer Inc. v. Ranbaxy Laboratories Limited | 2007-03-09 |
See all calcium carbonate; famotidine; magnesium hydroxide litigation
PTAB Litigation
| Petitioner | Date |
|---|---|
| Perrigo Company | 2014-09-26 |
See all calcium carbonate; famotidine; magnesium hydroxide litigation
Paragraph IV (Patent) Challenges for CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| PEPCID COMPLETE | TABLET, CHEWABLE;ORAL | calcium carbonate; famotidine; magnesium hydroxide | 020958 | 2004-11-01 |
US Patents and Regulatory Information for calcium carbonate; famotidine; magnesium hydroxide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | PEPCID COMPLETE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 020958-001 | Oct 16, 2000 | OTC | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Perrigo R And D | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 077355-001 | Feb 6, 2008 | OTC | No | No | Start Trial | Start Trial | Start Trial | ||||
| Perrigo R And D | FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 204782-001 | Aug 29, 2016 | OTC | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for calcium carbonate; famotidine; magnesium hydroxide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | PEPCID COMPLETE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 020958-001 | Oct 16, 2000 | Start Trial | Start Trial |
| J And J Consumer Inc | PEPCID COMPLETE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 020958-001 | Oct 16, 2000 | Start Trial | Start Trial |
| J And J Consumer Inc | PEPCID COMPLETE | calcium carbonate; famotidine; magnesium hydroxide | TABLET, CHEWABLE;ORAL | 020958-001 | Oct 16, 2000 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
